The collaboration aims to explore the field of biomolecular condensates to treat insulin resistance and diabetes progression.
A daring vision
There are times when a discovery is made, and its importance is astounding. The discovery of biomolecular condensates is a revelation so profound it completely transforms the understanding of cellular function and organization.
We have advanced this new foundational principle of cell biology to shape a daring vision - that the dysregulation of biomolecular condensates explains the root cause of complex diseases and paves the way to novel therapies[...]
To lead the way in the discovery of transformative condensate modulating therapies, Dewpoint has developed a fully integrated suite of technologies.
We combine expertise from complementary state-of-the-art experimental technologies with a powerful AI platform to develop powerful therapies across a broad range of therapeutic areas, including some of the most devastating diseases.